Tag: resverlogix

June 7, 2019

Resverlogix Closes $15 Million Offering

Resverlogix (TSX:RVX) has closed a $15 million offering of approximately 3.8 million units sold at $4 each. As quoted in...
April 1, 2019

Resverlogix Cognition Substudy of the BETonMACE Phase 3 Cardiovascular Trial Presented at the International Conference on Alzheimer’s & Parkinson’s Diseases

Resverlogix (TSX:RVX) has announced that Dr. Jeffrey Cummings, founding director of the Cleveland Clinic Lou Ruvo Brain Health Center, gave...
October 2, 2018

3 Top Biotech Stocks on the TSX Year-to-Date

Which biotech stocks on the TSX have performed the best year-to-date? These three companies have risen to the top of...
August 30, 2018

Resverlogix Announces $26 Million Private Placement

Resverlogix (TSX:RVX) announced today it has closed a private placement of approximately 10.4 million equity units at a price of...
August 1, 2018

Resverlogix Plans to Pursue US Listing

In light of several anticipated developments, Canadian biotech company Resverlogix says it intends to pursue a listing of its common...
August 1, 2018

Resverlogix Intends to Pursue U.S. Listing

Resverlogix (TSX:RVX) announced today that it intends to pursue a listing of its common shares in the United States. Accordingly,...
May 28, 2018

VIDEO Round-Up: BBHIC 2018

Here is the complete list of all our interviews with audio for investors to take a look at from the...